United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

wockhardt uk ltd - sulfadiazine - oral tablet - 500mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - sulfadiazine - oral tablet - 500mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - sulfadiazine - oral tablet - 500mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - sulfadiazine - oral tablet - 500mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ennogen healthcare ltd - sulfadiazine - oral tablet - 500mg

Canada - English - Health Canada

sanofi-aventis canada inc - trimipramine (trimipramine maleate) - tablet - 12.5mg - trimipramine (trimipramine maleate) 12.5mg - tricyclics and other norepinephrine-reuptake inhibitors

Canada - English - Health Canada

sanofi-aventis canada inc - trimipramine (trimipramine maleate) - tablet - 25mg - trimipramine (trimipramine maleate) 25mg - tricyclics and other norepinephrine-reuptake inhibitors

Canada - English - Health Canada

sanofi-aventis canada inc - trimipramine (trimipramine maleate) - tablet - 50mg - trimipramine (trimipramine maleate) 50mg - tricyclics and other norepinephrine-reuptake inhibitors

Canada - English - Health Canada

sanofi-aventis canada inc - trimipramine (trimipramine maleate) - tablet - 100mg - trimipramine (trimipramine maleate) 100mg - tricyclics and other norepinephrine-reuptake inhibitors

United States - English - NLM (National Library of Medicine)

lake erie medical & surgical supply dba quality care products llc - etodolac (unii: 2m36281008) (etodolac - unii:2m36281008) - etodolac 500 mg - carefully consider the potential benefits and risks of etodolac extended-release tablets and other treatment options before deciding to use etodolac extended-release tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). etodolac extended-release tablets are indicated: - for relief of signs and symptoms of juvenile arthritis. - for relief of the signs and symptoms of rheumatoid arthritis. - for relief of the signs and symptoms of osteoarthritis. etodolac extended-release tablets are contraindicated in patients with known hypersensitivity to etodolac. etodolac extended-release tablets should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings, anaphylactoid reactions and precautions, preexisting asthma ). etodolac extended-release tablets are contr